Gene therapy for Parkinson's disease

Molecular Neurobiology

Volumn 15, Issue 2, 1997, Pages 241-256

  Horellou, Philippe ^a   Mallet, Jacques ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Gene therapy; Glial cell line derived neurotrophic factor; Parkinson's disease; Recombinant adenovirus; Recombinant retrovirus; Tyrosine hydroxylase

Indexed keywords

DOPAMINE; GDNF PROTEIN, HUMAN; GDNF PROTEIN, RAT; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; HYBRID PROTEIN; NERVE GROWTH FACTOR; NERVE PROTEIN; OXIDOPAMINE; TYROSINE 3 MONOOXYGENASE;

ADENO ASSOCIATED VIRUS; ANIMAL; ASTROCYTE; CELL CULTURE; CELL SURVIVAL; CELL TRANSPLANTATION; CHEMICALLY INDUCED DISORDER; CORPUS STRIATUM; FIBROBLAST; GENE THERAPY; GENE VECTOR; GENETICS; HUMAN; HUMAN ADENOVIRUS; METABOLISM; NERVE CELL; NERVE DEGENERATION; PARKINSON DISEASE; PATHOLOGY; RAT; RETROVIRUS; REVIEW; STEM CELL; STEM CELL TRANSPLANTATION; TRANSPLANTATION;

ADENOVIRUSES, HUMAN; ANIMALS; ASTROCYTES; CELL SURVIVAL; CELL TRANSPLANTATION; CELLS, CULTURED; CORPUS STRIATUM; DEPENDOVIRUS; DOPAMINE; FIBROBLASTS; GENE THERAPY; GENETIC VECTORS; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HUMANS; NERVE DEGENERATION; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; NEURONS; OXIDOPAMINE; PARKINSON DISEASE; PARKINSON DISEASE, SECONDARY; RATS; RECOMBINANT FUSION PROTEINS; RETROVIRIDAE; STEM CELL TRANSPLANTATION; STEM CELLS; TYROSINE 3-MONOOXYGENASE;

EID: 0031240834     PISSN: 08937648     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02740636     Document Type: Article

References (93)

1. Akli S., Caillaud C., Vigne E., Stratford-Pierricaudet L. D., Poenaru L., Perricaudet M., Kahn A., and Peschanski M. (1993) Transfer of a foreign gene into the brain using adenovirus vectors. Nature Genet. 3, 224-228.
2. Anton R., Kordower J. H., Maidment N. T., Manaster J. S., Kane D. J., Rabizadeh S., Schneller S. B., Yang J., Rabizadeh S., Edwards R. H., Markham C. H., and Bredesen D. E. (1994) Neural-targeted gene therapy for rodent and primate hemi-parkinsonism. Exp. Neurol. 127, 207-218.
3. Bajocchi G., Feldman S. H., Crystal R. G., and Mastrangeli A. (1993) Direct in vivo gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vectors. Nature Genet. 3, 229-234.
4. Baltimore D. (1970) RNA-dependent DNA polymerase in virions of RNA tumour viruses. Nature 226, 1209-1211.
5. Beck K. D., Valverde J., Alexi T., Poulsen K., Moffat B., Vandlen R. A., Rosenthal A., and Hefti F. (1995) Mesencephalic dopaminergic neurons protected by GDNF from axotomyinduced degeneration in the adult brain. Nature 373, 339-341.
6. Bilang-Bleuel A., Revah F., Colin P., Locquet I., Robert J. J., Mallet J., and Horellou P. (1997) Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease. Proc. Natl. Acad. Sci. USA 94, 8818-8823.
7. Bjorklund A. and Stenevi U. (1979) Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants. Brain Res. 177, 555-560.
8. Bloom D. C., Maidment N. T., Tan A., Dissette V. B., Feldman L. T., and Stevens J. G. (1995) Longterm expression of a reporter gene from latent herpes simplex virus in the rat hippocampus. Mol. Brain Res. 31, 48-60.
9. Brundin P., Strecker R. E., Lindvall O., Isacson O., Nilsson O. G., Barbin G., Prochiantz A., Forni C., Nieoullon A., Widner H., Gage F. H., and Bjorklund A. (1987) Intracerebral grafting of dopamine neurons. Experimental basis for clinical trials in patients with parkinson's disease. Ann. NY Acad. Sci. 495, 473-496.
10. Buc-Caron M.-H. (1995) Neuroepithelial progenitor cells explanted from human fetal brain proliferate and differentiate in vitro. Neurobiol. Disease 2, 37-47.
11. Chen D. and Okayama H. (1987) High-efficiency transformation of mammalian cells by plasmid DNA Mol. Cell. Biol. 7, 2745-2752.
12. Choi-Lundberg D. L., Lin Q., Mohajeri H., Chang Y. N., Chiang Y. L., Hay C. M., Davidson B. L., and Bohn M. C. (1997) GDNF delivered via an adenoviral vector protects rat dopaminergic neurons from degeneration. Science 275, 838-841.
13. Colbere-Garapin F., Horodniceanu F., Kourilsky P., and Garapin A. C. (1981) A new dominant hybrid selective marker for higher eukaryotic cells. J. Mol. Biol. 150, 1-14.
14. Cone R. D., Weber-Benarous A., Baorto D., and Mulligan R. C. (1987) Regulated expression of a complete human β-globin gene encoded by a transmissible retrovirus vector. Mol. Cell. Biol. 7, 887-897.
15. Cunningham L. A., Hansen J. T., Short M. P., and Bohn M. C. (1991) The use of genetically altered astrocytes to provide nerve growth factor to adrenal chromaffin cells grafted into the striatum. Brain Res. 561, 192-202.
16. Danos O. and Mulligan R. C. (1988) Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc. Natl. Acad. Sci. USA 85, 6460-6464.
17. Davidson B. L., Allen E. D., Kozarsky K. F., Wilson J. M., and Roessler B. J. (1993) A model system for in vivo gene transfer into the central nervous system using an adenoviral vector. Nature Genet. 3, 219-223.
18. Dougherty J. P. and Temin H. M. (1987) A promoterless retroviral vector indicates that there are sequences in U3 required for 3′ RNA processing, Proc. Natl. Acad. Sci. USA 84, 1197-1201.
19. During M. J., Naegele J. R., O'Malley K. L., and Geller A. I. (1994) Long-term behavioral recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase. Science 266, 1399-1403.
20. Emerman M. and Temin H. M. (1984) Genes with promoters in retrovirus vectors can be independently suppressed by an epigenetic mechanism. Cell 39, 449-467.
21. Emerman M. and Temin H. M. (1984) High-frequency deletion in recovered retrovirus vectors containing exogenous DNA with promoters. J. Virol. 50, 42-49.
22. Fink D. J., Sternberg L. R., Weber P. C., Mata M., Goins W. F., and Glorioso J. C. (1992) In vivo expression of β-galactosidase in hippocampual neurons by HSV-mediated gene transfer. Hum. Gene Ther. 3, 12-19.
23. Fisher L. J., Jinnah H. A., Kale L. C., Higgins G. A., and Gage F. H. (1991) Survival and function of intrastriatally grafted primary fibroblasts genetically modified to produce L-Dopa. Neuron 6, 371-380.
24. Friedmann T. and Roblin R. (1972) Gene therapy for human genetic disease? Science 175, 949-955.
25. Ganem D., Nussbaum A. L., Davoli D., and Fareed G. C. (1976) Propagation of a segment of bacteriophage lambda-DNA in monkey cells after covalent linkage to a defective simian virus 40 genome. Cell 7, 349-359.
26. Gash D. M., Zhang Z., Ovadia A., Cass W. A., Yi A., Simmerman L., Russell D., Martin D., Lapchak P. A., Collins F., Hoffer B. J., and Gerhardt G. A. (1996) Functional recovery in GDNF-treated parkinsonian monkeys. Nature 380, 252-255.
27. Gilboa E., Goff S., Shields A., Yoshimura F., Mitra S., and Baltimore D. (1979) In vitro synthesis of a 9 kbp terminally redundant DNA carrying the infectivity of Moloney murine leukemia virus. Cell 16, 863-874.
28. Goff S. P. and Berg P. (1976) Construction of hybrid viruses containing SV40 and lambda phage DNA segments and their propagation in cultured monkey cells. Cell 9, 695-705.
29. Goldman M. J. and Wilson J. M. (1995) Expression of alpha v beta 5 integrin is necessary for efficient adenovirus-mediated gene transfer in the human airway. J. Virol. 69, 5951-5958.
30. Graham F. L., Smiley J., Russell W. C., and Nairn R. (1977) Characteristics of a human cell line transformed by DNA from human adenovirus 5. J. Gen. Virol. 36, 59-72.
31. Graham F. C. and van der Eb A. J. (1973) Anew technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52, 456-467.
32. Heidmann T., Heidmann O., and Nicolas J.-F. (1988) An indicator gene to demonstrate intracellular transposition of defective retroviruses. Proc. Natl. Acad. Sci. USA 89, 2219-2223.
33. Horellou P., Guibert B., Leviel V., and Mallet J. (1989) Retroviral transfer of a human tyrosine hydroxylase cDNA in various cell lines: regulated release of dopamine in mouse anterior pituitary AtT-20 cells. Proc. Natl. Acad. Sci. USA 86, 7233-7237.
34. Horellou P., Brundin P., Kalen P., Mallet J., and Bjorklund A. (1990a) In vivo release of DOPA and dopamine from genetically engineered cells grafted to the denervated rat striatum. Neuron 5, 393-402.
35. Horellou P., Marlier L., Privat A., and Mallet J. (1990b) Behavioural effect of engineered cells that synthesize L-DOPA or dopamine after grafting into the rat neostriatum. Eur. J. Neurosci. 2, 116-119.
36. Horellou P., Vigne E., Castel M. N., Barnéoud P., Colin P., Perricaudet M., Delaere P., and Mallet J. (1994) Direct intracerebral gene transfer of an adenoviral vector expressing tyrosine hydroxylase in a rat model of Parkinson's disease. Neuroreport 6, 49-53.
37. Hou J. G., Lin L. F., and Mytilineou C. (1996) Glial cell line-derived neurotrophic factor exerts neurotrophic effects on dopaminergic neurons in vitro and promotes their survival and regrowth after damage by 1-methyl-4-phenylpyridinium. J. Neurochem. 66, 74-82.
38. Huang S., Endo R. I., and Nemerow G. R. (1995) Upregulation of integrins alpha v beta 3 and alpha v beta 5 on human monocytes and 1 lymphocytes facilitates adenovirus-mediated gene delivery. J. Virol. 69, 2257-2263.
39. Kaplitt M. G., Leone P., Samulski R. J., Xiao X., Pfaff D. W., O'Malley K. L., and During M. J. (1994) Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nature Genet. 8, 148-154.
40. Kuehn M. R., Bradley A., Robertson E. J., and Evans M. J. (1987) A potential animal model for the human Lesch-Nyhan syndrome through introduction of HPRT mutations into mice. Nature 326, 295-298.
41. Le Gal La Salle G., Robert J. J., Berrard S., Ridoux V., Stratford-Perricaudet L. D., Perricaudet M., and Mallet J. (1993) An adenovirus vector for gene transfer into neurons and glia in the brain. Science 259, 988-990.
42. Lin L. F., Zhang T. J., Collins F., and Armes L. G. (1994) Purification and initial characterization of rat B49 glial cell line-derived neurotrophic factor. J. Neurochem. 63, 758-768.
43. Lin L. F., Doherty D. H., Lile J. D., Bektesh S., and Collins F. (1993) GDNF: a glial cell linederived neurotrophic factor for midbrain dopaminergic neurons. Science 260, 1130-1132.
44. Lindvall O., Sawle G., Widner H., Rothwell J. C., Bjorklund A., Brooks D., Brundin P., Frackowiak R., Marsden C. D., Odin P., et al. (1994) Evidence for long-term survival ancl function of dopaminergic grafts in progressive Parkinson's disease. Ann. Neurol. 35, 172-180.
45. Lindvall O., Brundin P., Widner H., Relmcrona S., Gustavii B., Frackowiak R., Leenders K. L., Sawle G., Rothwell J. C., Marsden C. D., and Bjorklund A. (1990) Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 247, 574-577.
46. Lundberg C., Horellou P., Mallet J., and Bjorklund A. (1996) Generation of DOPA-producing astrocytes by retroviral transduction of the human tyrosine hydroxylase gene: in vitro characterization and in vivo effects in the rat Parkinson model. Exp. Neurol. 139, 39-53.
47. Mallet J., Blanot F., Boni C., Dumas S., Faucon-Biguet N., Grima B., Horellou P., Julien J. F., Kahn P., Lamouroux A., et al. (1987) A molecularr genetic approach to the study of catecholamines. Biochem. Soc. Trans. 15, 126-128.
48. Mann R., Mulligan R. C., and Baltimore D. (1983) Construction of a packaging mutant and its use to produce helper-free defective retrovirus. Cell 33, 153-159.
49. Markowitz D., Goff S., and Bank A. (1988) A safe packaging line for gene transfer: separating viral genes on two different plasmids. J. Virol. 62, 1120-1124.
50. Marsden C. D. and Parkes J. D. (1976) "On-off" effects in patients with Parkinson's disease on chronic levodopa therapy. Lancet 1, 292-296.
51. Martin G. S. (1970) Rous sarcoma virus: a function required for the maintenance of the transformed state. Nature 227, 1021-1023.
52. Matsuse T., Namba Y., Ikeda K., Inoue S., Hosoi T., Ouchi Y., Fukuchi Y., and Orimo H. (1994) Immunohistochemical and in situ hybridisation detection of adenovirus early region 1A (ETA) gene in the microglia of human brain tissue. J. Clin. Pathol. 47, 275-277.
53. McCutchan J. H. and Pagano J. S. (1968) Enchancement of the infectivity of simian virus 40 deoxyribonucleic acid with diethyl-aminoethyl-dextran. J. Natl. Cancer Inst. 41, 351-357.
54. Moreau-Gachelin F., Tavitian A., and Tambourin P. (1988) Spi-1 is a putative oncogene in virally induced murine erythroleukaemias. Nature 331, 277-280.
55. Morgenstern J. P. and Land H. (1990) Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18, 3587-3596.
56. Mulligan R. C. and Berg P. (1980) Expression of a bacterial gene in mammalian cells. Science 209, 1422-1427.
57. Mulligan R. C. and Berg P. (1981) Selection for animal cells that express the E. coli gene coding for xanthine-guanine-phosphoribosyltransferase. Proc. Natl. Acad. Sci. USA 78, 2072-2076.
58. Mulligan R. C., Howard B. H., and Berg P. (1979) Synthesis of rabit β-globin in cultured monkey kidney cells following infection with a SV40 β-globin recombinant genome. Nature 277, 108-114.
59. Nandi A. K., Roginski R. S., Greeg R. G., Smithies O., and Skoultchi A. I. (1988) Regulated expression of genes inserted at the human chromosomal I3-globin locus by homologus recombination. Proc. Natl. Acad. Sci. USA 85, 3845-3849.
60. Neel B. G., Hayward W. S., Robinson H. L., Fang J., and Astrin S. M. (1981) Avian leukosis virus-induced tumors have common proviral integration sites and synthesize discrete new RNAs: oncogenesis by promoter insertion. Cell 23, 323-334.
61. Nussbaum A. L., Davoli D., Ganem D., and Fareed G. C. (1976) Construction and propagation of a defective simian virus 40 genome bearing an operator from bacteriophage lambda. Proc. Natl. Acad. Sci. USA 73, 1068-1072.
62. Onifer S. M., Whittemore S. R., and Holets V. R. (1993) Variable morphological differentiation of a rapine-derived neuronal cell line following transplantation into the adult rat CNS. Exp. Neurol. 122, 130-142.
63. Palella T. D., Hidaka Y., Silverman L. J., Levine M., Glorioso J., and Kelley W. N. (1989) Expression of human HPRT mRNA in brains of mice infected with a recombinant herpes simplex virus. Gene 80, 137-144.
64. Payne S. G., Courtneidge S. A., Crittenden L. B., Fadly A. M., Bishop J. M., and Varmus H. E. (1981) Analysis of avian leukosis virus DNA and RNA in bursar tumors: viral gene expression is not required for maintenance of tumor state. Cell 23, 311-322.
65. Perlow M. J., Freed W. J., Hoffer B. J., Seiger A., Olson L., and Wyatt R. J. (1979) Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system. Science 204, 643-646.
66. Renfranz P. J., Cunningham M. G., and McKay R. D. G. (1991) Region-specific differentiation of the hippocampal stem cell line HiB5 upon implantation into the developing mammalian brain. Cell 66, 713-729.
67. Revah F., Horellou P., Vigne E., Le Gal La Salle G., Robert J.-J., Perricaudet M., and Mallet J. (1996) Gene therapy of degenerative and genetic disorders of the central and peripheral nervous system using adenoviral vectors, in Gene Transfer into Neurones - Towards Gene Therapy of Neurological Disorders (Lowenstein P. and Enquist L., eds.), Wiley, Chister, UK, pp. 81-92.
68. Ridoux V., Robert J. J., Zhang X., Perricaudet M., Mallet J., and Le Gal La Salle G. (1994) Adenoviral vectors as functional retrograde neuronal tracers. Brain Res. 648, 171-175.
69. Rubin B. A. and Rorke L. B. (1988) Adenovirus vaccines, in Vaccines (Plotkin J. E. and Mortimer L. A., eds.), Saunders, Philadelphia, PA, pp. 492-512.
70. Sabate O., Horellou P., Vigne E., Colin P., Perricaudet M., Buc-Caron M. H., and Mallet J. (1995) Transplantation to the rat brain of human neural progenitors which were genetically modified using adenoviruses. Nature Genet. 9, 256-260.
71. Sauer H. and Oertel W. H. (1994) Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat. Neuroscience 59, 401-415.
72. Sauer H., Rosenblad C., and Bjorklund A. (1995) Glial cell line-derived neurotrophic factor but not transforming growth factor beta 3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion. Proc. Natl. Acad. Sci. USA 92, 8935-8939.
73. Shimotohono K. and Temin H. M. (1981) Formation of infectious progeny virus after insertion of herpes simplex thymidine kinase gene into DNA of an avian retrovirus. Cell 26, 67-77.
74. Shinnick T. M., Lerner R. A., and Sutcliffe J.-G. (1981) Nucleotide sequence of Moloney murine leukemia virus. Nature 293, 543-548.
75. Shults C. W., Kimber T., and Martin D. (1996) Intrastriatal injection of GDNF attenuates the effects of 6-hydroxydopamine. NeuroReport 7, 627-631.
76. Smithies O., Gregg R. G., Boggs S. S., Koralewski M. A., and Kucherlapati R. S. (1985) Insertion of DNA sequences into the human chromosomal β-globin locus by homologus recombination. Nature 317, 230-234.
77. Snyder E. Y., Deitcher D. L., Walsh C., Arnold-Aldea S., Hartwieg E. A., and Cepko C. L. (1992) Multipotent neural cell lines can engraft and participate in development of mouse cerebellum. Cell 68, 33-51.
78. Teich N., Wyke J., and Kaplan P. (1985) Pathogenesis of retrQvirus-induced disease, in RNA Tumor Virus (Weiss R., Teich N., Varmus H., and Coffin J., eds.), Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, pp. 187-248.
79. Temin H. M. and Mizutani S. (1970) RNA-dependent DNA polymerase in virions of Rous sarcoma virus. Nature 226, 1211-1213.
80. Thomas K. R., Folger K. R., and Capecchi M. R. (1986) High frequency targeting of genes to specific sites in the mammalian genome. Cell 44, 419-428.
81. Tomac A., Widenfalk J., Lin L.-F., Kohno T., Ebendal T., Hoffer B. J., and Olson L. (1995) Retrograde axonal transport of glial cell line-derived neurotrophic factor in the adult nigrostriatal system suggests a trophic role in the adult. Proc. Natl. Acad. Sci. USA 92, 8274-8278.
82. Uchida K., Ishii A., Kaneda N., Toya S., Nagatsu T., and Kohsaka S. (1990) Tetrahydrobiopterin-dependent production of L-DOPA in NRK fibroblasts transfected with tyrosine hydroxylase cDNA: future use for intracerebral grafting. Neurosci. Lett. 109, 282-286.
83. Ungerstedt U. and Arbuthnott G. W. (1970) Quantitative recording of rotational behavior in rats after 6-hydroxydopamine lesions of the nigrostriatal dopamine system. Brain Res. 24, 485-493.
84. Vogt P. K. (1971) Genetically stable reassortment of markers during mixed infection with avian tumor viruses. Virology 46, 947-952.
85. Watanabe S. and Temin H. M. (1982) Encapsidation sequences for spleen necrosis virus, an avian retrovirus, are between the 5′ long terminal repeat and the start of the gag gene. Proc. Natl. Acad. Sci. USA 79, 5986-5990.
86. Wickham T. J., Filardo E. J., Cheresh D. A., and Nemerow G. R. (1994) Integrin alpha v beta 5 selectively promotes adenovirus mediated cell membrane permeabilization. J. Cell Biol. 127, 257-264.
87. Wickham T. J., Mathias P., Cheresh D. A., and Nemerow G. R. (1993) Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell 73, 309-319.
88. Wigler M., Sweet R., Sim G., Wold B., Pellicer A., Lacy E., Maniatis T., Silverstein S., and Axel R. (1979) Transformation of mammalian cells with genes from prokaryotes and eukaryotes. Cell 16, 777-785.
89. Winkler C., Sauer H., Lee C. S., and Bjorklund A. (1996) Short-term GDNF treatment provides long-term rescue of lesioned nigral dopaminergic neurons in a rat model of Parkinson's Disease. J. Neurosci. 16, 7206-7215.
90. Wolfe J. D., Deshmane S. L., and Fraser N. W. (1992) Herpes virus vector gene transfer and expression of β-glucuronidase in the central nervous system of MPS VII mice. Nature Genet. 1, 379-384.
91. Wolff J. A., Fisher L. J., Xu L., Jinnah H. A., Langlais P. J., Iuvone P. M., O'Malley K. L., Rosenberg M. B., Shimohama S., Friedmann T., and Gage F. H. (1989) Grafting fibroblasts genetically modified to produce L-dopa in a rat model of Parkinson disease. Proc. Natl. Acad. Sci. USA 86, 9011-9014.
92. Yoshimoto Y., Lin Q., Collier T. J., Frim D. M., Breakefield X. O., and Bohn M. C. (1995) Astrocytes retrovirally transduced with BDNF elicit behavioral improvement in a rat model of Parkinson's disease. Brain Res. 691, 25-36.
93. Yu S.-F., von Runden T., Kantoff P. W., Garber C., Seiberg M., Ruther U., Anderson F. W., Wagner E. F., and Gilboa E. (1986) Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells. Proc. Natl. Acad. Sci. USA 83, 3194-3198.